C07K 2317/626
Diabody or triabody
C07K2317/626 (Diabody or triabody) appears on 468 US grants and 847 published applications in this corpus.
Search patents in C07K- Granted patents
- 468
- Published applications
- 847
- Assignees
- 314
- Inventors
- 1,372
- Latest grant
- 9 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 6 | 0 |
| 2001 | 1 | 2 |
| 2002 | 2 | 3 |
| 2003 | 2 | 3 |
| 2004 | 2 | 6 |
| 2005 | 0 | 15 |
| 2006 | 2 | 19 |
| 2007 | 4 | 14 |
| 2008 | 4 | 12 |
| 2009 | 3 | 28 |
| 2010 | 6 | 22 |
| 2011 | 10 | 21 |
| 2012 | 11 | 33 |
| 2013 | 9 | 29 |
| 2014 | 9 | 36 |
| 2015 | 35 | 49 |
| 2016 | 49 | 81 |
| 2017 | 38 | 61 |
| 2018 | 47 | 58 |
| 2019 | 35 | 52 |
| 2020 | 42 | 71 |
| 2021 | 30 | 57 |
| 2022 | 29 | 46 |
| 2023 | 26 | 36 |
| 2024 | 26 | 38 |
| 2025 | 30 | 28 |
| 2026 | 7 | 27 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- N-terminal scFv multispecific binding molecules9 Jun 2026US 12,649,796 B2Regeneron Pharmaceuticals, Inc.
- Multi-specific antibodies and methods of use2 Jun 2026US 12,643,949 B2Gritstone Bio, Inc.
- Molecular tools to visualize and target the cardiac conduction system (CCS)12 May 2026US 12,625,147 B2The Board of Trustees of the Leland Stanford Junior University
- Methods and compositions for reducing the immunogenicity of chimeric notch receptors5 May 2026US 12,617,825 B2Cell Design Labs, Inc.
- LAG-3-binding molecules and methods of use thereof14 Apr 2026US 12,600,779 B2MacroGenics, Inc.
- Tcr-mimic bispecific antibodies for hiv-11 Oct 2026US 2026/0297193 A1The Johns Hopkins University
- Bispecific polypeptides and uses thereof24 Sep 2026US 2026/0285997 A1Currus Biologics Pty Ltd
- Tetravalent FZD and WNT Co-Receptor Binding Antibody Molecules and Uses Thereof27 Aug 2026US 2026/0250398 A1Antlera Therapeutics Inc.
- Anti-muc17, anti-cd3 and anti-cd28 trispecific antibody20 Aug 2026US 2026/0242510 A1Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
- Dll3 antigen binding constructs13 Aug 2026US 2026/0234226 A1Imaginab, Inc.
Most cited
By later US patents
- Multivalent and multispecific binding proteins, their manufacture and use314US 5,837,242 ACambridge Antibody Technology Limited · 1998
- Multivalent and multispecific binding proteins and their use144US 6,492,123 B1Medical Research Council · 2002
- Recombinant production of mixtures of antibodies141US 7,262,028 B2Crucell Holland B. V. · 2007
- High affinity human antibodies to tumor antigens134US 5,977,322 AThe Regents of the University of California · 1999
- Multivalent antigen-binding proteins113US 5,869,620 AEnzon, Inc. · 1999